Primary Site >> Esophagus Cancer

Gene >> CDK4

  • 1995
  • 1996
  • 1997
  • 1998
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2006
  • 2007
  • 2011
  • 2012
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
Ref: MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines.
PMID: 7845688
Ref: Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.
PMID: 8595411
Ref: [RB gene expression in gastrointestinal tract].
PMID: 8920658
Ref: [The expression of Rb, p16 and cyclin D1 in 41 esophageal cancers].
PMID: 9388858
Ref: Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines.
PMID: 9414383
Ref: Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
PMID: 9214595
Ref: Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma.
PMID: 9683778
Ref: A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
PMID: 10910956
Ref: Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats.
PMID: 10969811
Ref: Insufficient effect of p27(KIP1) to inhibit cyclin D1 in human esophageal cancer in vitro.
PMID: 11115553
Ref: MDM2 and CDK4 expression in carcinosarcoma of the esophagus: comparison with squamous cell carcinoma and review of the literature.
PMID: 12565795
Ref: An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
PMID: 14612495
Ref: [Flow cytometric detection and significance of four cyclins in esophageal cancer].
PMID: 15634523
Ref: Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
PMID: 16506209
Ref: Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
PMID: 16732330
Ref: Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
PMID: 17320581
Ref: Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.
PMID: 21084391
Ref: Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer.
PMID: 22848289
Ref: MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo.
PMID: 22994740
Ref: Antitumor effect of metformin in esophageal cancer: in vitro study.
PMID: 23229592
Ref: Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin.
PMID: 23582790
Ref: Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1.
PMID: 23919806
Ref: Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
PMID: 25333998
Ref: Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway.
PMID: 26073339
Ref: miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
PMID: 27247259
Ref: miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4.
PMID: 27323123
Ref: Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.
PMID: 27453171
Ref: Identification of the Key Genes and Pathways in Esophageal Carcinoma.
PMID: 27818681
Ref: miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21.
PMID: 28402920
Ref: Phase I study of single-agent ribociclib in Japanese patients with advanced solid tumors.
PMID: 29059492
Ref: miR-486 functions as a tumor suppressor in esophageal cancer by targeting CDK4/BCAS2.
PMID: 29115564
Ref: Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway.
PMID: 29477843